Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve early diagnoses of Parkinson's disease.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises the importance of a timely diagnosis of Parkinson’s disease and the impact that early identification has on people’s long‑term outcomes. We remain committed to delivering the National Health Service constitutional standard for 92% of patients waiting no longer than 18 weeks from referral to treatment by March 2029. We are investing in additional capacity to deliver appointments to help bring lists and waiting times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard.
National programmes like NHS England’s Getting It Right First Time (GIRFT) support faster diagnosis by using clinically‑led, data‑driven reviews to identify delays and unwarranted variation in neurology services. GIRFT provides evidence‑based recommendations to streamline referral and outpatient pathways, improve data quality, and share best practice between NHS trusts. This helps increase specialist capacity, reduce waiting times for assessment, and ensure more timely access to diagnosis for people with suspected Parkinson’s disease.
Additionally, by delivering the shifts outlined in the 10‑Year Health Plan, we can free up specialist capacity by increasing community‑based provision, reducing administrative burden through digital tools, and supporting earlier identification and management of neurological conditions like Parkinson’s. This will allow neurologists and geriatricians to focus on more complex cases and improve diagnostic timeliness.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research on low grade glioma brain tumours.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department invests over £1.6 billion per year in research through the National Institute for Health and Care Research (NIHR).
The NIHR is continuing to invest in brain tumour research. In January 2026, the NIHR announced increased investment of over £25 million in the NIHR Brain Tumour Research Consortium. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours, ultimately reducing lives lost to cancer.
Brain tumours are one of the toughest cancers to treat. This new NIHR investment will help researchers and clinicians understand the disease better, test new treatments earlier, and make trials available to more adults and children closer to home.
The consortium brings together 48 organisations from across leading universities, National Health Service trusts and charities, along with patients, to help deliver better research, faster. It is a coordinated national effort to improve the development and evaluation of treatments for brain tumours across adult and paediatric populations.
The NIHR continues to welcome high quality funding applications for research into any aspect of human health and care, including low-grade glioma brain tumours.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the National Cancer Plan on support for people with brain tumours.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department recognises that there are currently limited treatment options available for people who have been diagnosed with brain tumours.
The National Cancer Plan, published on 4 February 2026, complements the 10-Year Health Plan and sets out how the National Health Service will improve outcomes for all cancer patients including those with rarer and less common cancers such as brain tumours.
Patients with rare cancers, including brain tumours, will benefit from a move to specialist multi-disciplinary teams which cover multiple providers. This will allow them to benefit from the input of specialist centres and so access to the best evidence-based care.
To meet its obligations for rare cancers, including brain tumours, the Government will appoint a new national clinical lead for rare cancers. This national clinical lead will have a clear mandate to speak up for rare cancers, and to provide clinical advice and support for the delivery of the actions in the plan.
In January 2026, the National Institute for Health and Care Research (NIHR) announced increased investment of over £25 million in the NIHR Brain Tumour Research Consortium. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours – ultimately reducing lives lost to cancer.
In addition to speeding up diagnosis and treatment, the work being undertaken by the consortium aims to ensure that patients have access to the latest treatments and technology and to clinical trials. This will make a significant contribution to bringing the United Kingdom’s cancer survival rates back up to the standards of the best in the world.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the National Cancer Plan will support people with secondary breast cancer.
Answered by Ashley Dalton
The National Cancer Plan, published 4 February 2026, will transform outcomes for people with secondary breast cancer.
The National Health Service is piloting the use of self-referral breast cancer pathways to streamline diagnostic pathways using the NHS App and NHS 111 online service. This is in addition to the Government’s commitment for the NHS to deliver 9.5 million additional tests by 2029 through a £2.3 billion investment in diagnostics. We are also ensuring as many community diagnostic centres as possible are fully operational and open 12 hours a day, seven days a week.
To improve the diagnosis of breast cancer, the NHS will harness 'circulating tumour DNA' tests for breast cancer, which can pick up relapse months earlier. This will accelerate clinical decisions and allow patients to start the most effective treatment faster.
The NHS will monitor the emerging evidence from the BRAID trial, which aims to determine whether additional imaging with one of several types of scans, is helpful in diagnosing breast cancer in women with dense breast tissue. This will target screening programmes at women who are at greater risk of cancer.
The NHS is also improving the experience of those with a cancer diagnosis. Every patient diagnosed with cancer will be supported through a full neighbourhood-level personalised care package, covering mental and physical health as well as any practical or financial concerns. For people with secondary breast cancer, this will be a step forward in building care around them, their needs, their lives, and their families.
We will harness data, as we begin counting metastatic disease, starting with breast cancer, so that people living with incurable cancer are properly recognised and better supported.
Through these National Cancer Plan actions, we will ensure that people with secondary breast cancer have faster diagnoses and treatment, access to the latest treatments and technology, and high-quality support throughout their journey, while we work to drive up this country’s cancer survival rates.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help support all medical graduates to access employment.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Last year, all eligible medical applicants were offered a place on the UK Foundation Programme, which provides medical graduates with employment as a doctor and which continues of their training.
The 10-Year Health Plan for England, published in July 2025, set out that over the next three years we would create 1,000 new specialty training posts with a focus on specialties where there is the greatest need.
On 8 December 2025, the Government put an offer in writing to the British Medical Association (BMA) Resident Doctors Committee which was rejected. The offer would have increased the number of training posts over the next three years from the 1,000 announced in the 10-Year Health Plan to 4,000, bringing forward 1,000 of these training posts to start in 2026. The BMA have rejected the Government's offer, so that is not going ahead. The Government will consider its next steps.
The Government will introduce the Medical Training (Prioritisation) Bill in Parliament, which will prioritise United Kingdom and Republic of Ireland medical graduates for foundation training, and prioritise UK and Republic of Ireland medical graduates and doctors who have worked in the National Health Service for a significant period of time for specialty training. Subject to parliamentary passage, this will apply to current applicants for training posts starting in 2026, and every year after that. This will reduce competition ratios for UK medical graduates and other prioritised applicants.
This is in addition to the steps already taken by NHS England in September to tackle competition for speciality training places this year by changing General Medical Council’s registration requirements and limiting the number of applications that can be submitted by individuals.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce (a) waste and (b) bureaucracy in the NHS.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government is taking action to reduce National Health Service bureaucracy by abolishing NHS England and reducing staff numbers by up to 50% across the Department, NHS England, and the NHS integrated care boards. These reductions will be made by March 2028. These changes will release savings that can be invested in frontline services, with up to 18,000 posts abolished and more than £1 billion a year saved in bureaucracy costs by the end of the Parliament.
In 2025/26, the NHS has ambitious plans to deliver to improve productivity and efficiency by 4%, including a 1% cost reduction. The efficiency savings target set for 2025/26 is £11 billion.
The Government has set a 2% annual productivity growth target for the NHS, unlocking £17 billion in savings over the next three years to reinvest in patient care. NHS productivity grew by 2.7% in 2024/25 and by 2.5% in the first five months of this financial year, putting the NHS on course to meet the target.
To support NHS productivity growth, the Government is investing £2 billion in digital infrastructure for 2025/26 and an additional £300 million announced in the Autumn Budget 2025. This will accelerate electronic patient record rollout, strengthen cyber security, expand the NHS App, and drive automation. The NHS App, for instance, has now saved over 730,000 hours of clinical time, and 3.2 million hours of administrative time across primary and secondary care, and over 860,000 outpatient “Did Not Attends” have been avoided due to patient use of the app, equating to £103 million in appointment costs.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) recruitment and (b) retention of managers in the NHS.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department is implementing a range of initiatives designed to attract talented individuals into management roles and support existing managers.
NHS England is developing an NHS Leadership and Management Framework, which sets clear expectations for leadership standards, behaviours, and ongoing development.
We are strengthening national and regional talent management systems to identify high-potential leaders and provide structured development pathways. We will also establish a new College of Executive and Clinical Leadership to provide a recognised professional home for National Health Service leaders and deliver high-quality training and development.
The new pay framework for Very Senior Managers (VSMs) aims to provide greater consistency of approach to VSM pay and helps ensure the total reward offered for VSMs remains attractive and proportionate.
These combined efforts aim to create a strong, effective, and accountable management workforce that can deliver transformation in the NHS, and to build a positive and compassionate culture.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the transition from analogue to digital across NHS services in Hornsey and Friern Barnet constituency.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The analogue to digital shift across National Health Services in Hornsey and Friern Barnet involves national initiatives like upgrading IT systems, developing integrated care systems, and utilizing digital tools for patient care.
Our goal is to make NHS healthcare more convenient, personalized, and efficient, creating a seamless experience for patients that is inclusive and accessible for all, and that provides staff with better access to information.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support those living with type 1 and 2 diabetes with the (a) cost of living and (b) the long term impact of those conditions in Hornsey and Friern Barnet constituency.
Answered by Ashley Dalton
To improve the provision of services for the treatment of type 1 and 2 diabetes in the Hornsey and Friern Barnet constituency, the North Central London Integrated Care System has commissioned a long-term conditions service. This supports the identification of individuals with diabetes and at high risk of a worsening condition, personalised care planning, and multidisciplinary collaboration. Community-based support includes diabetes specialist nurses, virtual clinics, and education for patients with diabetes who are starting GLP-1 medications or insulin therapy.
In north central London, the National Diabetes Prevention Programme is delivered by Living Well Taking Control. The programme offers a structured nine-month behavioural intervention designed to support individuals with diabetes in adopting healthier eating habits, increasing physical activity, achieving weight reduction, and sustaining long-term lifestyle changes. Those needing insulin and other medicines to manage diabetes are also entitled to free prescriptions.
Asked by: Catherine West (Labour - Hornsey and Friern Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the provision of services for the treatment of type (a) 1 and (b) 2 diabetes in Hornsey and Friern Barnet constituency.
Answered by Ashley Dalton
To improve the provision of services for the treatment of type 1 and 2 diabetes in the Hornsey and Friern Barnet constituency, the North Central London Integrated Care System has commissioned a long-term conditions service. This supports the identification of individuals with diabetes and at high risk of a worsening condition, personalised care planning, and multidisciplinary collaboration. Community-based support includes diabetes specialist nurses, virtual clinics, and education for patients with diabetes who are starting GLP-1 medications or insulin therapy.
In north central London, the National Diabetes Prevention Programme is delivered by Living Well Taking Control. The programme offers a structured nine-month behavioural intervention designed to support individuals with diabetes in adopting healthier eating habits, increasing physical activity, achieving weight reduction, and sustaining long-term lifestyle changes. Those needing insulin and other medicines to manage diabetes are also entitled to free prescriptions.